Gastroparesis Drugs Market Size to Grow at a CAGR of 4.8% by 2032

The global gastroparesis drugs market size was valued at USD 5.2 billion in 2023 and is projected to reach USD 7.6 billion by 2032, registering a CAGR of 4.8% during the forecast period (2024-2032). The market expansion is significantly driven by the Report Scope:<table><tr><td>Report Metric</td><td>Details</td></tr><tr><td><strong>Study Period</strong></td><td>2020-2032</td></tr><tr><td><strong>Historical Period</strong></td><td>2020-2022</td></tr><tr><td><strong>Forecast Period</strong></td><td>2024-2032</td></tr><tr><td><strong>Base Year</strong></td><td>2023</td></tr><tr><td><strong>Base Year Market Size</strong></td><td>USD 5.2 billion</td></tr><tr><td><strong>Forecast Year</strong></td><td>2032</td></tr><tr><td><strong>Forecast Year Market Size</strong></td><td>USD 7.6 billion</td></tr><tr><td><strong>Forecast Year CAGR</strong></td><td>4.8%</td></tr> <tr><td><strong>Largest Market</strong></td><td>North America</td></tr><tr><td><strong>Fastest Growing Market</strong></td><td>Europe</td></tr> </table>

全球胃轻瘫药物市场规模于2023年达到520亿美元，预计到2032年将增至760亿美元，在预测期内（2024-2032年）的复合年增长率将达到4.8%。市场的扩张动力主要源于以下报告范围：<table><tr><td>报告指标</td><td>详细信息</td></tr><tr><td><strong>研究周期</strong></td><td>2020-2032年</td></tr><tr><td><strong>历史周期</strong></td><td>2020-2022年</td></tr><tr><td><strong>预测周期</strong></td><td>2024-2032年</td></tr><tr><td><strong>基准年份</strong></td><td>2023年</td></tr><tr><td><strong>基准年份市场规模</strong></td><td>520亿美元</td></tr><tr><td><strong>预测年份</strong></td><td>2032年</td></tr><tr><td><strong>预测年份市场规模</strong></td><td>760亿美元</td></tr><tr><td><strong>预测年份CAGR</strong></td><td>4.8%</td></tr><tr><td><strong>最大市场</strong></td><td>北美</td></tr><tr><td><strong>增长最快的市场</strong></td><td>欧洲</td></tr></table>